Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.35    -0.10 (-0.61%)
Bid:
16.30
Ask:
16.45
Spread: 0.15 (0.92%)
Market Cap: £131.05m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Further Amendments To Long Term Retention Plan

26 Aug 2014 10:00

RNS Number : 9916P
Allocate Software PLC
26 August 2014
 



26 August 2014

 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

 

Further amendments to Long Term Retention Plan ("LTRP")

 

Following the announcement on 21 July 2014, and subsequent discussions with the Company's major shareholders and Numis, the Board has decided to make a further amendment to the performance conditions of the LTRP awarded to Ian Bowles in December 2011.

 

Background

Under the terms of the LTRP, Ian Bowles was awarded in December 2011, 1,000,000 nil-price options over ordinary shares in the Company which would vest between September 2014 and September 2016 subject to (a) the Company's earnings per share increasing at or above a 15% annual compound growth rate; and (b) a demanding absolute total shareholder return ("TSR") against which options would vest on a sliding scale. 20% of the options will vest at a 15% annual compound TSR and the options would vest in full at or above a 25% annual compound TSR.

On 21 July 2014, the Company announced that three principal changes had been made to the LTRP. Firstly, the targets for TSR were changed from a range of 15% - 25% to a range of 7.5% - 15%. Secondly, instead of 20% of the shares vesting at the minimum level of TSR achievement, the proportion that would vest at this level would change to 70%. Finally the earnings per share target were changed to an annual compound growth rate of 5%.

 

Further amendments

 

Following consultation with the Company's major shareholders and Numis, the Board has decided to make the amendments set out below.

 

400,000 ordinary shares will remain subject to the amendments announced in July 2014, and will vest immediately.

 

300,000 ordinary shares will vest in September 2015 (the "2015 Options") and a further 300,000 ordinary shares in September 2016 (the "2016 Options"). The 2015 Options and the 2016 Options are subject to the following performance conditions:

 

(a) EPS condition

 

The first 50% of the shares under option will be subject to the EPS condition which will be based on a minimum of 7.5% annual compound growth and a maximum of 15% annual compound growth.

 

If the minimum of 7.5% EPS growth is achieved then 33% of the first 50% of the shares will vest, if the maximum of 15% EPS growth is achieved then 100% of the first 50% of the shares will vest.

 

Where the EPS growth is between 7.5% and 15% then the number of shares vesting will be on a straight line basis between 33% and 100%.

 

(b) TSR condition

 

The second 50% of the shares under option will be subject to the TSR condition which is based on a minimum of 7.5% annual compound growth in TSR and a maximum of 20% annual compound growth in TSR.

 

If the minimum of 7.5% TSR growth is achieved then 33% of the second 50% of the shares will vest, if the maximum of 20% TSR growth is achieved then 100% of the second 50% of the shares will vest.

 

Where the TSR growth is between 7.5% and 20% then the number of shares vesting will be on a straight line basis between 33% and 100%.

 

 

The EPS condition and the TSR condition will apply separately to 50% of the shares under each option. It is no longer necessary to satisfy both conditions for any part of the option to vest.

 

 

 

 

 

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Simon Willis / Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Matt Dixon, Chris Lane

Tel : +44 (0) 20 3727 1000

 

 

About Allocate Software plc

Allocate Software is the leading workforce and corporate governance software solutions provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include Healthcare and Defence.

 

The experience and in-depth knowledge gained in the UK and internationally has enabled Allocate to invest in developing innovative solutions that are relevant to the constantly evolving market needs of its customers. At the core of the business is Allocate's workforce optimisation software, which streamlines the whole workforce management of multi-disciplinary groups, across diverse locations.

 

Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL).

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEISWMFLSEIA
Date   Source Headline
11th May 20267:00 amRNSElevra to Transfer Ewoyaa Rights and Obligations
7th May 20267:00 amRNSBinding Scheme Implementation Deed with Huayou
30th Apr 20267:00 amRNSQuarterly Activities and Cash Flow Report
20th Mar 20263:00 pmRNSTR-1 Notification of Major Holdings
20th Mar 20267:00 amRNSParliamentary Ratification of Ewoyaa Mining Lease
17th Mar 20261:03 pmRNSCorporate Funding Update - Amendment
17th Mar 20267:00 amRNSCorporate Funding Update
17th Mar 20267:00 amRNSCorporate Funding Update
13th Mar 20267:09 amRNSHalf-year Financial Report
13th Mar 20267:09 amRNSHalf-year Financial Report
23rd Feb 20267:00 amRNSCorporate Update
19th Feb 20268:27 amRNSASX Trading Halt
29th Jan 20267:00 amRNSQuarterly Activities and Cash Flow Report
22nd Dec 20257:00 amRNSRatification Process - Ewoyaa Mining Lease
22nd Dec 20257:00 amRNSRatification Process - Ewoyaa Mining Lease
11th Dec 20257:05 amRNSDirector/PDMR Dealings
11th Dec 20257:00 amRNSUpdate re the Ewoyaa Mining Lease
3rd Dec 20257:00 amRNSTR-1 Notification of Major Holdings
27th Nov 20259:25 amRNSResult of Annual General Meeting
27th Nov 20257:05 amRNSAGM Statement
27th Nov 20257:00 amRNSWithdrawal of AGM Resolution
26th Nov 20257:00 amRNSLong State Funding Update
12th Nov 20257:00 amRNSEwoyaa Lithium Project - Mining Lease Update
6th Nov 202510:07 amRNSResult of Extraordinary General Meeting
31st Oct 20257:00 amRNSQuarterly Activities and Cash Flow Report
28th Oct 20257:00 amRNSNotice of Annual General Meeting
20th Oct 20257:00 amRNSPronounced Lithium-in-soil Anomalies
7th Oct 20257:28 amRNSNotice of Extraordinary General Meeting
11th Sep 20257:00 amRNS2025 Annual Financial Report
9th Sep 20257:00 amRNSTR-1 Notification of Major Holdings
3rd Sep 20257:00 amRNSCorporate Funding Update
31st Jul 20257:00 amRNSQuarterly Activities and Cash Flow Report
18th Jul 20257:00 amRNSEwoyaa Lithium Project - Mining Lease Update
11th Jun 20257:00 amRNSLeadership Streamlining and Cost Reductions
22nd May 20257:00 amRNSSpodumene Pegmatite Discovered in Côte d’Ivoire
19th May 20257:00 amRNSLapse of PDMR Options
30th Apr 20257:00 amRNSQuarterly Activities and Cash Flow Report
24th Apr 202511:56 amRNSResponse to Media Reporting
4th Apr 20257:00 amRNSLapse of PDMR Options
14th Mar 20257:00 amRNSHalf-year Financial Report
4th Feb 20254:06 pmRNSResponse to Press Speculation
30th Jan 20257:15 amRNSQuarterly Activities and Cash Flow Report
30th Jan 20257:00 amRNSUpdated Ewoyaa Feldspar Resource Estimate
24th Jan 20257:00 amRNSResignation of Non-Executive Director
23rd Dec 20247:00 amRNSGrant of Performance Rights
16th Dec 20247:00 amRNSTR-1 Notification of Major Holdings
10th Dec 20247:00 amRNSIssue of Equity
29th Nov 20247:51 amRNSResult of AGM
29th Nov 20247:00 amRNSAGM Statement
26th Nov 20247:00 amRNSStatement re Proposed Merger of PLL and SYA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.